The antioxidant butylated hydroxytoluene can retard cerebellar degeneration induced transplacentally by a single low dosage of N‐methyl‐n‐nitrosourea

Sylvia B. Smith, Carol Beck Cooke, K. Lemone Yielding

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Late‐onset cerebellar degeneration can be induced transplacentally in mice by a single low‐dose (1 mg/kg) injection of the direct‐acting DNA alkylating agent N‐methyl‐N‐nitrosourea (MNU) on day 16 of pregnancy. The offspring develop a mild ataxia that manifests by 12–16 weeks of age postnatally when the animals are challenged with a motor coordination task. Morphological evidence of degeneration includes pyknosis of Purkinje cells and abnormal foliation patterns. Additionally, these animals demonstrate a progressive retinopathy characterized by thinning of the nuclear and plexiform layers of the retina. Efforts to retard the cerebellar degeneration were undertaken in the present study. MNU‐exposed and control animals were fed a standard mouse chow diet supplemented with 0.75% butylated hydroxytoluene (BHT), an antioxidant. This supplementation commenced 24 h following exposure to the teratogen and continued throughout the life of the offspring. A second group of MNU‐exposed and control mice were fed a non‐BHT‐supplemented, standard Purina mouse chow diet. Quantitative histological evaluation of cerebellar coronal sections indicated that by 4 weeks of age BHT‐fed, MNU‐exposed mice had significantly fewer pyknotic Purkinje cells than non‐BHT‐fed, MNU‐exposed animals. This was true for the vermal, paravermal, and lateral areas of the cerebellum. The findings suggest the usefulness of teratogenic models of degenerative diseases for the testing of potential intervention strategies.

Original languageEnglish (US)
Pages (from-to)15-27
Number of pages13
JournalTeratogenesis, Carcinogenesis, and Mutagenesis
Volume9
Issue number1
DOIs
StatePublished - 1989

Fingerprint

Butylated Hydroxytoluene
Animals
Antioxidants
Nutrition
Purkinje Cells
Teratogens
Alkylating Agents
Diet
Ataxia
Cerebellum
Retina
DNA
Testing
Pregnancy
Control Groups
Injections

Keywords

  • Purkinje cell
  • alkylating agent
  • antioxidant diet
  • degenerative neuronal disease
  • mouse

ASJC Scopus subject areas

  • Oncology
  • Genetics
  • Toxicology
  • Genetics(clinical)
  • Health, Toxicology and Mutagenesis

Cite this

@article{6c47a692262d4f03a1712a742dd84e79,
title = "The antioxidant butylated hydroxytoluene can retard cerebellar degeneration induced transplacentally by a single low dosage of N‐methyl‐n‐nitrosourea",
abstract = "Late‐onset cerebellar degeneration can be induced transplacentally in mice by a single low‐dose (1 mg/kg) injection of the direct‐acting DNA alkylating agent N‐methyl‐N‐nitrosourea (MNU) on day 16 of pregnancy. The offspring develop a mild ataxia that manifests by 12–16 weeks of age postnatally when the animals are challenged with a motor coordination task. Morphological evidence of degeneration includes pyknosis of Purkinje cells and abnormal foliation patterns. Additionally, these animals demonstrate a progressive retinopathy characterized by thinning of the nuclear and plexiform layers of the retina. Efforts to retard the cerebellar degeneration were undertaken in the present study. MNU‐exposed and control animals were fed a standard mouse chow diet supplemented with 0.75{\%} butylated hydroxytoluene (BHT), an antioxidant. This supplementation commenced 24 h following exposure to the teratogen and continued throughout the life of the offspring. A second group of MNU‐exposed and control mice were fed a non‐BHT‐supplemented, standard Purina mouse chow diet. Quantitative histological evaluation of cerebellar coronal sections indicated that by 4 weeks of age BHT‐fed, MNU‐exposed mice had significantly fewer pyknotic Purkinje cells than non‐BHT‐fed, MNU‐exposed animals. This was true for the vermal, paravermal, and lateral areas of the cerebellum. The findings suggest the usefulness of teratogenic models of degenerative diseases for the testing of potential intervention strategies.",
keywords = "Purkinje cell, alkylating agent, antioxidant diet, degenerative neuronal disease, mouse",
author = "Smith, {Sylvia B.} and Cooke, {Carol Beck} and {Lemone Yielding}, K.",
year = "1989",
doi = "10.1002/tcm.1770090104",
language = "English (US)",
volume = "9",
pages = "15--27",
journal = "Teratogenesis Carcinogenesis and Mutagenesis",
issn = "1542-9733",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - The antioxidant butylated hydroxytoluene can retard cerebellar degeneration induced transplacentally by a single low dosage of N‐methyl‐n‐nitrosourea

AU - Smith, Sylvia B.

AU - Cooke, Carol Beck

AU - Lemone Yielding, K.

PY - 1989

Y1 - 1989

N2 - Late‐onset cerebellar degeneration can be induced transplacentally in mice by a single low‐dose (1 mg/kg) injection of the direct‐acting DNA alkylating agent N‐methyl‐N‐nitrosourea (MNU) on day 16 of pregnancy. The offspring develop a mild ataxia that manifests by 12–16 weeks of age postnatally when the animals are challenged with a motor coordination task. Morphological evidence of degeneration includes pyknosis of Purkinje cells and abnormal foliation patterns. Additionally, these animals demonstrate a progressive retinopathy characterized by thinning of the nuclear and plexiform layers of the retina. Efforts to retard the cerebellar degeneration were undertaken in the present study. MNU‐exposed and control animals were fed a standard mouse chow diet supplemented with 0.75% butylated hydroxytoluene (BHT), an antioxidant. This supplementation commenced 24 h following exposure to the teratogen and continued throughout the life of the offspring. A second group of MNU‐exposed and control mice were fed a non‐BHT‐supplemented, standard Purina mouse chow diet. Quantitative histological evaluation of cerebellar coronal sections indicated that by 4 weeks of age BHT‐fed, MNU‐exposed mice had significantly fewer pyknotic Purkinje cells than non‐BHT‐fed, MNU‐exposed animals. This was true for the vermal, paravermal, and lateral areas of the cerebellum. The findings suggest the usefulness of teratogenic models of degenerative diseases for the testing of potential intervention strategies.

AB - Late‐onset cerebellar degeneration can be induced transplacentally in mice by a single low‐dose (1 mg/kg) injection of the direct‐acting DNA alkylating agent N‐methyl‐N‐nitrosourea (MNU) on day 16 of pregnancy. The offspring develop a mild ataxia that manifests by 12–16 weeks of age postnatally when the animals are challenged with a motor coordination task. Morphological evidence of degeneration includes pyknosis of Purkinje cells and abnormal foliation patterns. Additionally, these animals demonstrate a progressive retinopathy characterized by thinning of the nuclear and plexiform layers of the retina. Efforts to retard the cerebellar degeneration were undertaken in the present study. MNU‐exposed and control animals were fed a standard mouse chow diet supplemented with 0.75% butylated hydroxytoluene (BHT), an antioxidant. This supplementation commenced 24 h following exposure to the teratogen and continued throughout the life of the offspring. A second group of MNU‐exposed and control mice were fed a non‐BHT‐supplemented, standard Purina mouse chow diet. Quantitative histological evaluation of cerebellar coronal sections indicated that by 4 weeks of age BHT‐fed, MNU‐exposed mice had significantly fewer pyknotic Purkinje cells than non‐BHT‐fed, MNU‐exposed animals. This was true for the vermal, paravermal, and lateral areas of the cerebellum. The findings suggest the usefulness of teratogenic models of degenerative diseases for the testing of potential intervention strategies.

KW - Purkinje cell

KW - alkylating agent

KW - antioxidant diet

KW - degenerative neuronal disease

KW - mouse

UR - http://www.scopus.com/inward/record.url?scp=0024405913&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024405913&partnerID=8YFLogxK

U2 - 10.1002/tcm.1770090104

DO - 10.1002/tcm.1770090104

M3 - Article

C2 - 2567066

AN - SCOPUS:0024405913

VL - 9

SP - 15

EP - 27

JO - Teratogenesis Carcinogenesis and Mutagenesis

JF - Teratogenesis Carcinogenesis and Mutagenesis

SN - 1542-9733

IS - 1

ER -